Intra-individual Open-label, Single Center Study to Compare Unenhanced MRI With Dotarem Enhanced MRI in Pediatric and Neonatal Patient Population (<18years)

Trial Profile

Intra-individual Open-label, Single Center Study to Compare Unenhanced MRI With Dotarem Enhanced MRI in Pediatric and Neonatal Patient Population (<18years)

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 17 Mar 2017

At a glance

  • Drugs Gadoterate-meglumine (Primary)
  • Indications CNS disorders
  • Focus Diagnostic use
  • Sponsors Guerbet
  • Most Recent Events

    • 13 Mar 2017 Planned End Date changed from 1 Jan 2018 to 8 Feb 2018.
    • 13 Mar 2017 Planned primary completion date changed from 1 Jan 2018 to 8 Feb 2018.
    • 13 Mar 2017 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top